| 000 | 00949 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516124407.0 | ||
| 264 | 0 | _c20130514 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1530-8561 | ||
| 024 | 7 |
_a10.1373/clinchem.2012.199455 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArnaout, Ramy | |
| 245 | 0 | 0 |
_aPredicting the cost and pace of pharmacogenomic advances: an evidence-based study. _h[electronic resource] |
| 260 |
_bClinical chemistry _cApr 2013 |
||
| 300 |
_a649-57 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aGenomics |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 | _aPharmacogenetics |
| 700 | 1 | _aBuck, Thomas P | |
| 700 | 1 | _aRoulette, Paulvalery | |
| 700 | 1 | _aSukhatme, Vikas P | |
| 773 | 0 |
_tClinical chemistry _gvol. 59 _gno. 4 _gp. 649-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1373/clinchem.2012.199455 _zAvailable from publisher's website |
| 999 |
_c22337243 _d22337243 |
||